Identification of 2,4-Di--Butylphenol as an Antimicrobial Agent Against Bacteria from Rwandan Propolis.

Background/objectives: Acne is the most prevalent dermatological condition among humans, affecting approximately 80% of adolescents during puberty. To date, numerous compounds have been used for acne treatment, including erythromycin ointments and antiseptics, with varying degrees of success. The emergence of erythromycin-resistant strains has spurred the search for new antimicrobial agents, particularly from natural sources.

Methods: Propolis collected in Rwanda was extracted and fractionated by flash chromatography and tested against growth by using NCLSI recommendations.

Results: In our research, we identified a molecule, 2,4-Di--butylphenol (2,4-DTBP) which inhivbited the growth at a concentration of 16 µg/mL. Based on these results, we formulated an ointment (1%) using OFAP18 and petroleum jelly for the potential treatment of acne using a mouse model.

Conclusions: In vitro and in vivo evidence suggests that 2,4-DTBP has anti-inflammatory properties and could effectively manage the overgrowth of as well as serve as a potent alternative for the formulation of an active propolis ointment for acne treatment.